Richardson Peter C
Insider CIK 1343502 · ATRS See Remarks · MNK EVP & Chief Scientific Officer · MNKD Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NONE Mallinckrodt plc | A Award deriv | 2025-07-31 | 2025-08-04 | 20,518 | — | $0 | 27,357 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise deriv | 2025-01-01 | 2025-01-02 | 3,419 | — | $0 | 6,839 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise | 2025-01-01 | 2025-01-02 | 3,419 | — | $0 | 3,419 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2024-02-02 | 2024-02-06 | 10,258 | — | $0 | 10,258 | SEC↗ |
| MNKTQ Mallinckrodt plc | D To issuer | 2023-11-14 | 2023-11-16 | 75,091 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | D To issuer deriv | 2023-06-30 | 2023-07-05 | 127,861 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | A Award deriv | 2023-04-03 | 2023-04-05 | 127,861 | — | $0 | 127,861 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2023-02-02 | 2023-02-03 | 75,091 | — | $0 | 75,091 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 59,179 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 69,037 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 36,199 | $5.60 | $202.7K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 14,414 | $5.60 | $80.7K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 69,037 | — | $0 | 69,037 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 36,199 | $4.42 | $160.0K | 36,199 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-04-26 | 2021-04-28 | 59,179 | — | $0 | 59,179 | SEC↗ |
| MNKD MANNKIND CORP | F Tax w/h | 2012-03-03 | 2012-03-06 | 3,143 | $2.28 | $7.2K | 133,611 | SEC↗ |